XORTX Therapeutics Inc. (XRTX)
0.3791
+0.0341 (9.88%)
Inactive · Last trade price on Mar 27, 2026
XORTX Therapeutics Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Quarter | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Sep '25 Sep 30, 2025 | Jun '25 Jun 30, 2025 | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Sep '24 Sep 30, 2024 | Jun '24 Jun 30, 2024 | Mar '24 Mar 31, 2024 | Dec '23 Dec 31, 2023 | Sep '23 Sep 30, 2023 | Jun '23 Jun 30, 2023 | Mar '23 Mar 31, 2023 | Dec '22 Dec 31, 2022 | Sep '22 Sep 30, 2022 | Jun '22 Jun 30, 2022 | Mar '22 Mar 31, 2022 | Dec '21 Dec 31, 2021 | Sep '21 Sep 30, 2021 |
Selling, General & Admin | 0.26 | 0.61 | 0.49 | 0.39 | 0.47 | 0.48 | 0.41 | 0.53 | 0.79 | 0.46 | 0.49 | 0.5 | 0.76 | 0.53 | 0.45 | 0.46 | 0.41 | 0.61 | 0.59 | -0.16 |
Research & Development | 0.11 | 0.03 | 0.05 | 0.06 | 0.19 | 0.28 | 0.01 | 0.03 | 0.07 | 0.07 | 0.13 | 0.57 | 0.67 | 1.05 | 1.9 | 1.47 | 1.46 | 1.93 | 0.34 | 0.3 |
Amortization of Goodwill & Intangibles | 0 | 0 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | -0 | 0.01 | 0.05 | 0.01 | 0 | 0 | 0 | 0 | 0 |
Operating Expenses | 0.39 | 0.68 | 0.58 | 0.48 | 0.69 | 0.79 | 0.45 | 0.61 | 0.94 | 0.62 | 0.68 | 1.11 | 1.49 | 1.68 | 2.45 | 1.98 | 2.21 | 2.61 | 1.05 | 0.2 |
Operating Income | -0.39 | -0.68 | -0.58 | -0.48 | -0.69 | -0.79 | -0.45 | -0.61 | -0.94 | -0.62 | -0.68 | -1.11 | -1.49 | -1.68 | -2.45 | -1.98 | -2.21 | -2.61 | -1.05 | -0.2 |
Interest Expense | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | -0 | -0 |
Interest & Investment Income | 0 | 0 | 0 | 0.01 | 0.01 | 0.02 | 0.03 | 0.03 | 0.04 | 0.03 | 0.05 | 0.06 | 0.07 | 0.07 | 0.05 | 0.04 | 0.01 | 0 | - | - |
Currency Exchange Gain (Loss) | -0 | 0.01 | 0 | -0.02 | 0.01 | 0 | -0.06 | 0.01 | -0.02 | -0.01 | -0.01 | -0 | -0 | 0.01 | -0.63 | 0.51 | 0.27 | -0.16 | 0.27 | -0.01 |
Other Non Operating Income (Expenses) | -1.3 | -0.14 | -0.01 | -0.16 | -0.05 | 0.07 | 0.61 | -0.02 | 1.09 | -2.42 | 3.33 | -0.28 | -0.27 | -0.23 | 0.44 | 0.24 | 0.68 | 0.06 | 7.96 | -6.4 |
EBT Excluding Unusual Items | -1.69 | -0.81 | -0.59 | -0.65 | -0.72 | -0.7 | 0.12 | -0.59 | 0.17 | -3.02 | 2.7 | -1.33 | -1.69 | -1.83 | -2.58 | -1.2 | -1.24 | -2.7 | 7.19 | -6.61 |
Asset Writedown | - | - | -0 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Pretax Income | -1.69 | -0.81 | -0.59 | -0.65 | -0.72 | -0.7 | 0.12 | -0.59 | 0.17 | -3.02 | 2.7 | -1.33 | -1.69 | -1.83 | -2.58 | -1.2 | -1.24 | -2.7 | 7.19 | -6.61 |
Net Income | -1.69 | -0.81 | -0.59 | -0.65 | -0.72 | -0.7 | 0.12 | -0.59 | 0.17 | -3.02 | 2.7 | -1.33 | -1.69 | -1.83 | -2.58 | -1.2 | -1.24 | -2.7 | 7.19 | -6.61 |
Net Income to Common | -1.69 | -0.81 | -0.59 | -0.65 | -0.72 | -0.7 | 0.12 | -0.59 | 0.17 | -3.02 | 2.7 | -1.33 | -1.69 | -1.83 | -2.58 | -1.2 | -1.24 | -2.7 | 7.19 | -6.61 |
Net Income Growth (YoY) | - | - | - | - | - | - | -95.46% | - | - | - | - | - | - | - | - | - | - | - | - | - |
Shares Outstanding (Basic) | 2 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Shares Outstanding (Diluted) | 2 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Shares Change (YoY) | 113.52% | 86.30% | 99.77% | 67.26% | 30.47% | 53.84% | 63.88% | 45.26% | 45.26% | 25.91% | 25.74% | 38.49% | 38.49% | 33.68% | 15.70% | 38.17% | 38.54% | 57.76% | 78.80% | 35.96% |
EPS (Basic) | -1.05 | -0.58 | -0.45 | -0.67 | -0.95 | -0.93 | 0.19 | -1.01 | 0.29 | -6.21 | 6.75 | -3.34 | -4.23 | -4.75 | -8.11 | -4.15 | -4.29 | -9.37 | 26.15 | -31.63 |
EPS (Diluted) | -1.05 | -0.58 | -0.45 | -0.67 | -0.95 | -0.93 | 0.19 | -1.01 | 0.29 | -6.21 | 6.75 | -3.35 | -4.25 | -4.75 | -8.12 | -4.15 | -4.29 | -9.37 | 26.15 | -31.63 |
EPS Growth (YoY) | - | - | - | - | - | - | -97.24% | - | - | - | - | - | - | - | - | - | - | - | - | - |
Additional Metrics
Fiscal Quarter | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Sep '25 Sep 30, 2025 | Jun '25 Jun 30, 2025 | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Sep '24 Sep 30, 2024 | Jun '24 Jun 30, 2024 | Mar '24 Mar 31, 2024 | Dec '23 Dec 31, 2023 | Sep '23 Sep 30, 2023 | Jun '23 Jun 30, 2023 | Mar '23 Mar 31, 2023 | Dec '22 Dec 31, 2022 | Sep '22 Sep 30, 2022 | Jun '22 Jun 30, 2022 | Mar '22 Mar 31, 2022 | Dec '21 Dec 31, 2021 | Sep '21 Sep 30, 2021 |
Free Cash Flow | -3.27 | -0.5 | -0.7 | -0.63 | -0.79 | -0.64 | -0.89 | -0.75 | -0.74 | -1.3 | -1.3 | -1.07 | -1.73 | -2.49 | -3.62 | -0.97 | -1.89 | -2.5 | -3.12 | -0.06 |
Free Cash Flow Per Share | -2.02 | -0.36 | -0.54 | -0.65 | -1.05 | -0.86 | -1.35 | -1.29 | -1.27 | -2.68 | -3.25 | -2.68 | -4.33 | -6.45 | -11.38 | -3.35 | -6.56 | -8.67 | -11.37 | -0.29 |
EBITDA | -0.39 | -0.68 | -0.57 | -0.47 | -0.66 | -0.77 | -0.45 | -0.58 | -0.9 | -0.59 | -0.67 | -1.09 | -1.46 | -1.61 | -2.44 | -1.96 | -2.2 | -2.61 | -1.04 | -0.19 |
D&A For EBITDA | 0 | 0 | 0.01 | 0.01 | 0.03 | 0.03 | 0.01 | 0.03 | 0.03 | 0.03 | 0.01 | 0.02 | 0.03 | 0.07 | 0.01 | 0.02 | 0.01 | 0 | 0 | 0 |
EBIT | -0.39 | -0.68 | -0.58 | -0.48 | -0.69 | -0.79 | -0.45 | -0.61 | -0.94 | -0.62 | -0.68 | -1.11 | -1.49 | -1.68 | -2.45 | -1.98 | -2.21 | -2.61 | -1.05 | -0.2 |